HemaXis is contributing in clinical trial to better understand COVID-19
Healthcare organizations, research institutions and the whole…
Are blood tests possible without seeing a doctor?
Conventional blood sampling
Conventional blood sampling/testing…
Volume controlled Dried Blood Spot (DBS): A key player in personalized medicine
Dried blood spot sampling and subsequent analysis is an area…
Cansford Laboratories turns to HemaXis DB 10 for sampling in their PEth testing program
HemaXis DB 10 is Cansford Laboratories Ltd. solution for microsampling…
Zaragoza University uses HemaXis for Hg quantification
The group of Prof. Resano of Zaragoza University Department of…
HemaXis DB 10 available at Cibesmed
If you need fully customised kits which could include device,…
HemaXis DB 10 application presented in the German Symposium
Frank Sporkert & Cristian Palmiere will present, during…
DISCLAIMER
HemaXis DB is a FDA Class 1 medical device. HemaXis DX is in development and for research purposes only. Use of HemaXis devices in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with local regulatory requirements.
By using this website you are agreeing to our Terms and Conditions.
CONTACT
DBS System SA
Rte des Avouillons 6
CH-1196 Gland
Switzerland
Tel: +41 (0) 78 624 70 15
Email: info@dbs-system.ch
LEGAL DOCUMENTS
Read Our Privacy Policy
Read Our General Terms and Conditions of Sale
Read Our Shipping Information